Eurofins CDMO Alphora Inc. (Canada) Announces the Relocation and Expansion of its Analytical Services and Research & Development Laboratories to New Campus Hosting all Biopharmaceutical Activities
January 11 2023 - 10:17AM
Business Wire
Eurofins CDMO Alphora Inc. is pleased to announce the relocation
and expansion of its API development laboratories from 2395
Speakman Drive to its new, owned facility at 2070 Hadwen Road,
located within the Sheridan Research Park in Mississauga, Ontario,
Canada.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230111005622/en/
(Photo: Business Wire)
This 56,000 square foot building is the new home of Eurofins
CDMO Alphora Inc’s API process R&D activity, solid-state
R&D activity and its analytical services team. The
state-of-the-art laboratory facility includes 26 fume hoods
supporting Process R&D; a 50L scale Kilo laboratory equipped
with 6 walk-in fume hoods; cGMP Analytical Services; HPAPI
development laboratories; a new Bruker 400 mHz NMR; as well as
offices for employees and client meetings. The new facility expands
capacity to support the continued growth of client programs and
offers new Kilo Laboratory services for larger quantities of
preclinical materials for toxicological studies.
The 2070 Hadwen site seamlessly fits into Eurofins CDMO Alphora
Inc’s vision for its 14-acre campus located over two nearly
adjacent sites within the Sheridan Research Park, establishing a
suite of complementary and integrated service offerings to support
biopharmaceutical development. The new Hadwen API development
laboratories are located nearly opposite the corporate site at 2240
Speakman Drive, which also houses drug product development and
manufacturing, quality assurance, the newly completed 100L scale
GMP HPAPI facility (2022), and a 2000L scale GMP API plant
(operational mid-2023). The campus is also within 2.5 km of
Eurofins CDMO Alphora Inc.’s existing API production facility.
This latest addition is another important step towards Eurofins
CDMO Alphora Inc’s’ vision to build out its Sheridan Research Park
campus with additional capacity and technologies in CDMO and
biopharmaceutical services.
To learn more, please visit: www.eurofins.com/cdmo
About Eurofins CDMO: Eurofins CDMO is a leading global
Contract Development and Manufacturing Organization that provides
clients with active pharmaceutical ingredients (“API’s”) / drug
substance and drug product development for small molecules and
biologics. Its service offering encompasses drug substance/API
development, solid state research and development, pre-formulation,
formulation and development, analytical development, GMP
manufacturing and clinical packaging and logistics. Operating with
facilities in Europe, North America and India, Eurofins CDMO is
accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and
Health Canada.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With over 61,000 staff across a
network of 940 laboratories in 59 countries, Eurofins’ companies
offer a portfolio of over 200,000 analytical methods. Eurofins
Shares are listed on Euronext Paris Stock Exchange.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230111005622/en/
For further information: Cheryl Young, HBSc. VP Business
Development & Project Management Eurofins CDMO Alphora Inc.
Cheryl.Young@bpt.eurofinsca.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024